Prostate cancer decisions — 2024

The Veteran's prostate cancer is remanded due to a pre-decisional duty to assist error and the need for an examination. The PACT Act requires VA to provide a medical examination and obtain a medical opinion when there is evidence of a disability, participation in a TERA, and such evidence is not sufficient to establish service connection.

The Veteran's claim for an effective date earlier than August 10, 2022 for service connection of hypertension has been granted. The Veteran's claim for a rating in excess of 10 percent for service-connected tinnitus is denied.

The Board has remanded the claim of service connection for prostate cancer due to new evidence submitted in a supplemental claim, and because the Veteran is considered to have participated in a toxic exposure risk activity (TERA) during service. The VA examiner must provide an opinion regarding whether it is at least as likely as not that the prostate cancer began in or is otherwise caused by the Veteran's active service, including his in-service exposure to chemicals.

The Board dismissed the appeal for service connection for prostate cancer from August 10, 2022. The effective date of the grant of service connection for prostate cancer was set at April 11, 2019.

The Veteran's prostate cancer is granted as service connected due to presumed exposure to Agent Orange during his military service.

The Board has remanded the case due to a duty to assist error and requires an additional medical opinion regarding the relationship between the Veteran's prostate cancer and service, specifically chemical exposure at Fort Lewis and Fort Ord.

The Board has remanded the case due to a duty to assist error in furnishing an adequate medical opinion, and another medical opinion is needed to resolve the appeal regarding service connection for prostate cancer.

The Board has dismissed the appeals for service connection for diabetes mellitus, type II, hypertension, prostate cancer, and bilateral peripheral neuropathy as they have been granted in a previous decision.

The Board has granted service connection for prostate cancer and hypothyroidism, finding that the Veteran's exposure to herbicide agents during his service in Vietnam is presumed. The appeal of these issues is granted.

The Veteran's diabetes mellitus type II and prostate cancer are granted as service-connected due to exposure to herbicide agents during his service in Thailand.

The Board has remanded the claims for esophageal cancer, diverticula of intestine, prostate cancer, hypertension, and hernia testicle due to inservice exposures during training at Ft. Leonard Wood, MO.

The Veteran's claim for an increased evaluation for his service-connected prostate cancer has been remanded due to the AOJ not providing notice of a hearing opportunity.

Your claim for service connection for prostate cancer has been granted, and you are now receiving a full rating. The appeal is dismissed as moot because the benefits sought have already been awarded.

The Veteran's bilateral feet have lost all effective function due to service-connected diabetic peripheral neuropathy, and he requires regular aid and attendance of another due to multiple service-connected disabilities. His claim for SMC is granted.

The Veteran's appeal for an increased disability rating higher than 10% for tinnitus was denied as the maximum schedular rating is already assigned.,The Veteran's appeal for an increased disability rating higher than 20% for prostate cancer residuals prior to May 7, 2024 was denied. A 40% rating from that date forward was granted.,The Veteran's appeals for increased disability ratings for DM II with erectile dysfunction and postoperative cataracts, as well as right lower extremity diabetic peripheral neuropathy affecting the sciatic and femoral nerves were not addressed in this decision.,The appeal for left lower extremity diabetic peripheral neuropathy disabilities was remanded.

The Veteran's service-connected residuals of prostate cancer with urinary incontinence have rendered him unable to secure and follow a substantially gainful occupation.

The Veteran's claim for a 40% rating for bilateral hearing loss is granted with an effective date of March 29, 2019.

The Veteran's prostate cancer, thyroid condition, hypertension, right hip arthritis, sleep apnea, depression, anxiety, and insomnia disabilities are denied as not related to service.,The Veteran's lumbago with arthritis disability is remanded for further examination.

The Veteran's appeals for service connection on multiple conditions were dismissed due to the death of the Veteran.

The Board has granted service connection for prostate cancer from August 10, 2022, pursuant to the PACT Act. The Veteran's exposure during his service in Kuwait is presumed toxic exposure.